The TBCRC-056 trial showed a 50% pCR rate in TNBC patients with BRCA or PALB2 mutations treated with niraparib and dostarlimab. sTILs increased significantly in both treatment arms, with higher ...
Lung cancer screening can detect cancer early when it’s most treatable. See if you qualify for a low-dose CT scan at Fred Hutch.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback